Sign in
CompletedNo phase

MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

Key facts

Who runs it
Dopavision GmbH
Where
Germany, Netherlands, Portugal, Spain, and United Kingdom10 sites in 5 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
124 people enrolled
Started
16 Nov 2021
Ended
4 Oct 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • MyopiaX
  • Myopia control spectacles
Record updated
28 October 2024

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Myopic children (-0.75 to -5.0 D SER, least myopic meridian -0.50 D in each eye)
  • At least VA 0.2 LogMAR in each eye
  • Age: 6 - 12 years old
  • Good tolerability of test session with VR system
  • Binocular adequacy as tested with VR
  • Ability to understand treatment and give valid assent

Who cannot take part

  • Concomitant or previous therapies for myopia
  • Eye diseases/conditions:
  • Systemic illnesses affecting eye health, eye growth, and/or refraction
  • Any illnesses affecting dopamine function (e.g., sleep disorder)
  • Medication affecting dopamine function, accommodation, pupil size, or having an impact on the ocular surface (such as allergy medications)
  • Medical history (or family history) of photosensitive epilepsy
  • Anisometropia ≥ 1.5 D
  • Astigmatism ≥ 3 D
  • Ophthalmological comorbidities
  • Optic nerve abnormalities
  • Suspicion of syndromic or monogenetic myopia
  • Participation in other clinical studies

This trial has no sites in United States.

It has sites in 5 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this trial is to investigate the safety and efficacy of MyopiaX - a digital treatment intended to slow the progression of myopia in children and adolescents.

The 2 groups in the trial

  • MyopiaXTreatment being tested

    MyopiaX treatment

  • Myopia control spectaclesExisting treatment, for comparison

    Clinically validated treatment to control myopia

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
28 October 2024